Importance of Sulfonylimidazolidinone Motif of 4-Phenyl-1-arylsulfonylimidazolidinones for Their Cytotoxicity: Synthesis of 2-Benzoyl-4-phenyl[1,2,5]thiazolidine-1,1-dioxides and Their Cytotoxcity

  • Published : 2003.01.01

Abstract

For probing the importance of planarity of imidazolidinone motif of 4-phenyl-1-(benzenesulfonyl)imidazolidinones 1 for their cytotoxicity, 4-phenyl-2-(benzoyl)[1,2,5]thiadiazolidine-1,1-dioxide (2a), 4-phenyl-2-(p-toluoyl)[1,2,5]thiadiazolidine-1,1-dioxide (2b), 4-phenyl-2-(phenylcarbamoyl)[1,2,5]thiadiazolidine-1,1-dioxide (3a), and 4-phenyl-2-(p-tolylcarbamoyl)[1,2,5]thiadiazolidine-1,1-dioxide (3b) were prepared along with their regioisomers (5a, 5b, 9a, 9b) and their cytotoxicity were measured against human lung carcinoma (A549), human colon carcinoma (COLO205), human ovarian cancer (SK-OV-3), human leukemic cancer (K562), and murine colon adenocarcinoma (Colon26) cell lines in vitro. All compounds prepared do not show any activity against all five cancer cell lines unlike 1. Compounds 1 possess planarity of imidazolidinone, especially in sulfonylurea moiety ($-SO_2$NHCONH-). However compounds 2 and 3 have nonplanar 5-membered ring, [1,2,5]thiadiazolidine-1,1-dioxides. Such structural differentiation might result in the loss of activity. Therefore the inactivity of 2 and 3 could also be an indication for the necessity of planarity of imidazolidinone ring of 1 for their cytotoxic activity.

Keywords

References

  1. Everitt, E., Wohlfart, C., Spectrometric quantitation of anchoragedependent cell numbers extraction of naphthol blue-blackstained cellular protein. Anal. Biochem., 162, 122-129 (1987) https://doi.org/10.1016/0003-2697(87)90016-9
  2. Howbert, J. J., Grossman, C. S., Crowell, T. A., Rieder, B. J., Harper, R. W., Kramer, K. E., Tao, E. V., Aikins, J., Poore, G. A., Rinzel, S. M., Grindey, G. B., Shaw, W. N., Todd, G. C., Novel Agents Effective against Solid Tumors: The Diarylsulfonylureas. Synthesis, Activities, and Analysis of Quantitative Structure-Activity Relationships. J. Med. Chem., 33, 2393-2407 (1990) https://doi.org/10.1021/jm00171a013
  3. Hwang, H.-S., Moon, E.-Y., Seong, S.-K., Choi, C.-H., Chung, C.-H., Jung, S.-H., Yoon, S.-J., Characterization of the anticancer activity of DW2282, a new anticancer agent. Anticancer Res., 1999, 19, 5087-5093
  4. Jung, S.-H., Song, J.-S., Lee, H.-S., Choi, S.-U., Lee, C.-O., Synthesis and evaluation of cytotoxicity of novel arylsulfonylimidazolidinones containing sulfonylurea pharmacophore. Arch. Pharm. Res., 19, 570-580 (1996) https://doi.org/10.1007/BF02986031
  5. Jung, S.-H., Song, J.-S., Lee, H.-S., Choi, S.-U., Lee, C.-O., Synthesis and evaluation of cytotoxic activity of novel arylsulfonylimidazolidinones. Bioorg. & Med. Chem. Letters, 6, 2553-2558 (1996) https://doi.org/10.1016/0960-894X(96)00463-5
  6. Jung, S.-H., Kwak, S.-J., Planar structural requirement at 4-position of 1-arylsulfonyl-4-phenyl-4,5-dihydro-2-imidazolones for their cytotoxicity. Arch. Pharm. Res., 20, 283-287 (1997) https://doi.org/10.1007/BF02976159
  7. Jung, S.-H., Lee, H.-S., Song, J.-S., Kim, H.-M., Han, S.-B., Lee, C.-W., Lee, M., Choi, D.-R., Lee, J.-A., Chung, Y.-H., Yoon, S.- J., Moon, E.-Y., Hwang, H.-S., Seong, S.-K., Lee, D.-K., Synthesis and antitumor activity of 4-phenyl-1-arylsulfonylimidazolidinones. Bioorg. & Med. Chem. Letters, 8, 2553-2558 (1997)
  8. Jung, S.-H., Kwak, S.-J., Kim, N.-D., Lee, S.-U., Lee, C.-O., Stereochemical Requirement at 4-Position of 4-Phenyl-1-arylsulfonylimidazolidinones for their Cytotoxicities. Arch. Pharm. Res., 23, 35-41 (2000) https://doi.org/10.1007/BF02976463
  9. Lee, H.-S., Park, K.-L., Choi, S.-H, Lee C.-O., and Jung, S.-H., Effect of substituents on Benzenesulfonyl Motif of 4-phenyl-1-arylsulfonylimidazolidinones for their cytotoxicity. Arch. Pharm. Res., 23, 579-584 (2000) https://doi.org/10.1007/BF02975244
  10. Park, K.-L., Moon, B.-G., Jung, S.-H., Kim, J.-G., Suh, I.-H., Multicenter Hydrogen Bonds in a 2:1 arylsulfonylimidazolone hydrochloride salt. Acta Crystallography, C56,1247-1250 (2000)
  11. Perrin, D. D., Armarego, W. L. F., and Perrin, D. R., Purification of laboratory chemicals, 2nd edition. Pergamon Press, Oxford, England, (1982)
  12. Skehan, P., Storeng, R., Scudiero, D. A., Monks, A., MacMahon, J., Vista, D. T., Kenny, S., Boyd, M. R. New colorimetric cytotoxicity assay for anticancer drug screening. J. Natl. Cancer Inst., 82, 1107-1112 (1990) https://doi.org/10.1093/jnci/82.13.1107